Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, in specific cases, for weight management
dorei , Lachnoclostridium , and Mitsuokella independently predicted glycemic response to GLP-1 RA therapy
Investigators have reported reductions in wrinkle depth, improvements in skin density, and increased dermal fibroblast activity in pre-clinical and limited human-skin studies [2][6]
Acta 1853 , 27222730 (2015)
MEN-related cancers include: Medullary thyroid cancer Pancreatic neuroendocrine tumors Duodenal gastrinomas Small bowel neuroendocrine tumors Adrenal tumors If a patient has a personal or family history of these specific endocrine cancers, GLP-1 inhibitors are not recommended, says Dr
The present study demonstrated that GSTP1 could enhance the expression of STAT3 to promote the proliferation, invasion and metastasis of CRC cells, which provides a potential therapeutic target for the clinical treatment of CRC